The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease-Reference-Cited by-同舟云学术

The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease

Published:2017-08-23 Issue:4 Volume:33 Page:586-597
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Hamano Hirofumi¹²,Ikeda Yasumasa¹^ORCID,Watanabe Hiroaki³,Horinouchi Yuya¹,Izawa-Ishizawa Yuki¹,Imanishi Masaki²,Zamami Yoshito²³,Takechi Kenshi⁴,Miyamoto Licht⁵,Ishizawa Keisuke²³,Tsuchiya Koichiro⁵,Tamaki Toshiaki¹

Affiliation:

1. Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

2. Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan

3. Department of Clinical Pharmacology and Therapeutics, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

4. Clinical Trial Center for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan

5. Department of Medical Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

Funder

University of Tokushima

JSPS

Ichiro Kanehara Foundation for the Promotion of Medical Sciences and Medical Care

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/33/4/586/24525005/gfx252.pdf

Reference52 articles.

1. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis;Collins;Clin J Am Soc Nephrol,2009

2. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization;Go;N Engl J Med,2004

3. Hepcidin, a urinary antimicrobial peptide synthesized in the liver;Park;J Biol Chem,2001

4. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization;Nemeth;Science,2004

5. Hepcidin—a potential novel biomarker for iron status in chronic kidney disease;Zaritsky;Clin J Am Soc Nephrol,2009

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction;International Journal of Molecular Sciences;2024-03-27

2. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice;eLife;2024-02-27

3. The AKI-to-CKD Transition: The Role of Uremic Toxins;International Journal of Molecular Sciences;2023-11-10

4. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice;ELIFE;2023-09-28

5. Microbial-Derived Uremic Toxins: Role in the Pathogenesis of Comorbidities in Patients with Chronic Kidney Disease;Russian Journal of Gastroenterology, Hepatology, Coloproctology;2023-09-11